|
|
|
Financials-Ajanta Pharma Limited| Sector: Formulations | | BSE:532331 | NSE:AJANTPHARM | Bloomberg:AJP@IN | Reuters:AJPH.BO | | Market Lot: 1 | Face Value: 2 | ISIN Demat: INE031B01049 |
|
|
| |
| Financials (Standalone) |
|
|
|
|
../financials/latestHalf.php
| Latest Quarterly/Halfyearly |
|
| As On(Months) |
31-Mar-2021(3) |
31-Mar-2020(3) |
% Change |
| Sales of Products/Services |
7480.70 |
5606.80 |
33.42 |
| Other Operating Income |
0.00 |
0.00 |
-- |
| Other Income |
13.30 |
541.00 |
-97.54 |
| Total Income |
7494.00 |
6147.80 |
21.90 |
| Total Expenses |
-5326.50 |
-4826.50 |
10.36 |
| OPBDIT |
12820.50 |
10974.30 |
16.82 |
| Interest |
0.00 |
0.00 |
-- |
| Depreciation |
-294.80 |
-4826.50 |
-93.89 |
| Exceptional & Extraordinary Items |
0.00 |
-25.10 |
-- |
| Prior Period Adjustments |
0.00 |
0.00 |
-- |
| Provision for Tax |
-619.70 |
-411.10 |
50.74 |
| After Tax Profit |
1547.80 |
885.10 |
74.87 |
| Equity Capital |
0.00 |
0.00 |
-- |
| Reserves |
0.00 |
0.00 |
-- |
| Notes to Accounts |
|
|
|
|
| As on( Months ) |
31-Mar-07(12) |
|
31-Mar-06(12) |
|
31-Mar-05(12) |
|
| Profit / Loss A/C |
Rs mn |
%OI |
Rs mn |
%OI |
Rs mn |
%OI |
| Net Sales |
2386.45 |
99.80 |
2060.11 |
99.90 |
1753.36 |
99.51 |
| Operating Income (OI) |
2391.14 |
100.00 |
2062.09 |
100.00 |
1761.94 |
100.00 |
| OPBDIT |
365.46 |
15.28 |
290.99 |
14.11 |
215.86 |
12.25 |
| OPBDT |
249.90 |
10.45 |
179.54 |
8.71 |
124.31 |
7.06 |
| OPBT |
182.12 |
7.62 |
117.65 |
5.71 |
65.02 |
3.69 |
| Non-Operating Income |
1.61 |
0.07 |
0.92 |
0.04 |
0.34 |
0.02 |
| Extraordinary/Prior Period |
-38.37 |
-1.60 |
-11.53 |
-0.56 |
8.51 |
0.48 |
| Tax |
8.30 |
0.35 |
3.58 |
0.17 |
-0.52 |
-0.03 |
| Profit after tax(PAT) |
137.06 |
5.73 |
103.46 |
5.02 |
74.39 |
4.22 |
| Cash Profit |
204.83 |
8.57 |
165.35 |
8.02 |
133.67 |
7.59 |
| Dividend-Equity |
23.42 |
0.98 |
17.56 |
0.85 |
0.00 |
0.00 |
|
| As on |
31-Mar-07 |
|
31-Mar-06 |
|
31-Mar-05 |
|
| Assets |
Rs mn |
%BT |
Rs mn |
%BT |
Rs mn |
%BT |
| Gross Block |
995.55 |
36.58 |
869.20 |
39.11 |
813.96 |
39.83 |
| Net Block |
563.72 |
20.71 |
499.07 |
22.46 |
468.50 |
22.93 |
| Capital WIP |
134.41 |
4.94 |
0.00 |
0.00 |
0.00 |
0.00 |
| Investments |
165.19 |
6.07 |
149.47 |
6.73 |
149.46 |
7.31 |
| Inventory |
689.34 |
25.33 |
627.60 |
28.24 |
604.27 |
29.57 |
| Receivables |
757.19 |
27.82 |
693.47 |
31.21 |
596.25 |
29.18 |
| Other Current Assets |
411.86 |
15.13 |
252.68 |
11.37 |
225.06 |
11.01 |
| Balance Sheet Total(BT) |
2721.70 |
100.00 |
2222.29 |
100.00 |
2043.54 |
100.00 |
| Liabilities |
Rs mn |
%BT |
Rs mn |
%BT |
Rs mn |
%BT |
| Equity Share Capital |
117.96 |
4.33 |
117.96 |
5.31 |
117.96 |
5.77 |
| Reserves |
1088.19 |
39.98 |
978.53 |
44.03 |
895.10 |
43.80 |
| Total Debt |
1084.80 |
39.86 |
827.62 |
37.24 |
800.70 |
39.18 |
| Creditors and Acceptances |
364.95 |
13.41 |
268.86 |
12.10 |
229.04 |
11.21 |
| Other current liab/prov. |
65.80 |
2.42 |
29.32 |
1.32 |
0.74 |
0.04 |
| Balance Sheet Total(BT) |
2721.70 |
100.00 |
2222.29 |
100.00 |
2043.54 |
100.00 |
|
| As on |
31-Mar-07 |
31-Mar-06 |
31-Mar-05 |
| OPBIT/Prod.cap.empl.(%) |
14.95 |
12.91 |
9.41 |
| PBIT/Cap. Employed (%) |
12.10 |
11.36 |
9.12 |
| PAT/Networth (%) |
11.36 |
9.44 |
7.34 |
| Tax/PBT (%) |
5.71 |
3.34 |
-0.70 |
| Total Debt/Networth (x) |
0.90 |
0.75 |
0.79 |
| Long Term Debt/Networth (x) |
0.25 |
0.23 |
0.37 |
| PBDIT/Finance Charges (x) |
2.84 |
2.52 |
2.45 |
| Current Ratio (x) |
4.31 |
5.28 |
6.20 |
| RM Inventory (days consumption) |
76.46 |
106.30 |
106.88 |
| FG inventory (days cost of sales) |
68.84 |
59.33 |
70.51 |
| Receivables (days gross sales) |
111.83 |
119.18 |
121.72 |
| Creditors (days cost of sales) |
65.76 |
55.41 |
54.07 |
| Op. curr. assets (days OI) |
271.00 |
257.00 |
267.00 |
|
|
Financials